Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Title Image

IMITINIB DRUG RESISTANT ANALYSIS BY RT PCR AND RESTRICTION ANALYSIS

Home  /  IMITINIB DRUG RESISTANT ANALYSIS BY RT PCR AND RESTRICTION ANALYSIS

IMITINIB DRUG RESISTANT ANALYSIS BY RT PCR AND RESTRICTION ANALYSIS

Imatinib is a Tyrosine kinase inhibitor (TKI) capable of inducing durable hematologic and cytologic remissions in patients with Chronic Myeloid Leukemia (CML). Unfortunately a significant subset of patients develop functional resistance to TKI. Recognition of this resistance is important in CML as the effect of some mutations can be overcome by Imatinib dosage.

Pre-test Information : Submit latest BCR-ABL Quantitative report along with sample

Report Delivery : Daily

IMITINIB DRUG RESISTANT ANALYSIS BY RT PCR AND RESTRICTION ANALYSIS

Test Code I-001
Test Description **IMITINIB DRUG RESISTANT ANALYSIS BY RT PCR AND RESTRICTION ANALYSIS
Clinical Category THERAPEUTIC DRUG MONITORING
Sample 4 mL Whole blood in EDTA tube
Method/Technology PCR, Sequencing
Storage/Temp
Reporting Time